EUVIMEDEUVIMED entdecken
Open Access

Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2

Iris C R M Kolder, Michael W T Tanck, Pieter G Postema, Julien Barc, Moritz F Sinner, Sven Zumhagen, Anja Husemann, Birgit Stallmeyer, Tamara T Koopmann, Nynke Hofman, Arne Pfeufer, Peter Lichtner und 10 weitere

Circulation: Cardiovascular Genetics · 2015-06 · 8 (3) · 447-456

DOI: 10.1161/circgenetics.114.000785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Genetics, 2015-06. Verfasst von Iris C R M Kolder und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Cardiology (I.C.R.M.K., P.G.P., J.B., T.T.K., A.A.M.W., C.R.B.), Department of Clinical Epidemiology, Biostat…. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background— Considerable interest exists in the identification of genetic modifiers of disease severity in the long-QT syndrome (LQTS) as their identification may contribute to refinement of risk stratification. Methods and Results— We searched for single-nucleotide polymorphisms (SNPs) that modulate the corrected QT (QTc)-interval and the occurrence of cardiac events in 639 patients harboring different mutations in KCNH2 . We analyzed 1201 SNPs in and around 18 candidate genes, and in another approach investigated 22 independent SNPs previously identified as modulators of QTc-interval in genome-wide association studies in the general population. In an analysis for quantitative effects on the QTc-interval, 3 independent SNPs at NOS1AP (rs10494366, P =9.5×10 −8 ; rs12143842, P =4.8×10 −7 ; and rs2880058, P =8.6×10 −7 ) were strongly associated with the QTc-interval with marked effects (>12 ms/allele). Analysis of patients versus general population controls uncovered enrichment of QTc-prolonging alleles in patients for 2 SNPs, located respectively at NOS1AP (rs12029454; odds ratio, 1.85; 95% confidence interval, 1.32–2.59; P =3×10 −4 ) and KCNQ1 (rs12576239; odds ratio, 1.84; 95% confidence interval, 1.31–2.60; P =5×10 −4 ). An analysis of the cumulative effect of the 6 NOS1AP SNPs by means of a multilocus genetic risk score (GRS NOS1AP ) uncovered a strong linear relationship between GRS NOS1AP and the QTc-interval ( P =4.2×10 −7 ). Furthermore, patients with a GRS NOS1AP in the lowest quartile had a lower relative risk of cardiac events compared with patients in the other quartiles combined ( P =0.039). Conclusions— We uncovered unexpectedly large effects of NOS1AP SNPs on the QTc-interval and a trend for effects on risk of cardiac events. For the first time, we linked common genetic variation at KCNQ1 with risk of long-QT syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingAdrenergic beta-AntagonistsAllelesCase-Control StudiesElectrocardiographyFemaleGenome-Wide Association StudyGenotypeHumansKCNQ1 Potassium ChannelLong QT SyndromeMaleOdds RatioPolymorphism, Single NucleotideRisk FactorsSeverity of Illness Index

Stichwörter der Autor:innen

arrhythmias, cardiacion channelslong-QT syndrome

Substanzen

Adaptor Proteins, Signal TransducingAdrenergic beta-AntagonistsKCNQ1 Potassium ChannelKCNQ1 protein, humanNOS1AP protein, human

Autor:innen und Institutionen

  • Department of Clinical and Experimental Cardiology (I.C.R.M.K., P.G.P., J.B., T.T.K., A.A.M.W., C.R.B.), Department of Clinical Epidemiology, Biostatistics and Bioinformatics (I.C.R.M.K., M.W.T.T.), and Department of Cl…

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Kolder, I. C. R. M., Tanck, M. W. T., Postema, P. G., Barc, J., Sinner, M. F., Zumhagen, S., Husemann, A., Stallmeyer, B., Koopmann, T. T., Hofman, N., Pfeufer, A., Lichtner, P., Meitinger, T., Beckmann, B. M., Myerburg, R. J., Bishopric, N. H., Roden, D. M., Kääb, S., Wilde, A. A. M., …, & Bezzina, C. R. (2015). Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2. Circulation: Cardiovascular Genetics, 8(3), 447-456. https://doi.org/10.1161/circgenetics.114.000785

Vancouver

Kolder ICRM, Tanck MWT, Postema PG, Barc J, Sinner MF, Zumhagen S, et al. Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2. Circulation: Cardiovascular Genetics. 2015;8(3):447-456. doi:10.1161/circgenetics.114.000785

BibTeX
@article{Kolder2015,
  author = {Kolder, Iris C R M and Tanck, Michael W T and Postema, Pieter G and Barc, Julien and Sinner, Moritz F and Zumhagen, Sven and Husemann, Anja and Stallmeyer, Birgit and Koopmann, Tamara T and Hofman, Nynke and Pfeufer, Arne and Lichtner, Peter and Meitinger, Thomas and Beckmann, Britt M and Myerburg, Robert J and Bishopric, Nanette H and Roden, Dan M and Kääb, Stefan and Wilde, Arthur A M and Schott, Jean-Jacques and Schulze-Bahr, Eric and Bezzina, Connie R},
  title = {Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2},
  journal = {Circulation: Cardiovascular Genetics},
  year = {2015},
  volume = {8},
  number = {3},
  pages = {447--456},
  doi = {10.1161/circgenetics.114.000785}
}
Kostenlos starten →